Measurement of placental lactogen in undiluted serum by radioimmunoassay utilizing polyethylene glycol as separating agent. Values obtained in pregnancy. 1982

P Englebienne, and G Doyen, and R Dervaux, and J P Billemont

We describe a simple and reliable radioimmunoassay (RIA) method for the measurement of human placental lactogen (hPL) in undiluted serum. Standard curves, in serum, cover the range of 0.015 to 1 mlU/L for early pregnancy monitoring (7 to 15 weeks, referred to as Procedure I), and 0.531 to 17 mIU/L for mid and late pregnancy monitoring (16 to 40 weeks, referred to as Procedure II). In a typical assay, 0.05 mL of serum are incubated with constant amounts of antiserum and 125I-hPL for 1 hour (in Procedure I), or 30 minutes (in Procedure II). At the end of the incubation, a 260g/L polyethylene glycol solution is added, in order to bring the polymer concentration in the assay tube to 130g/L. The tube contents are mixed and centrifuged. The supernatant is removed and the precipitate counted. The antiserum dilution for both procedures was chosen after classical titration without and with addition of 0.531 mIU/L of unlabelled hPL; the titration was performed with the desired incubation time of 30 minutes. This technique showed a good correlation with a solid phase second antibody RIA (r = 0,95; n = 215).

UI MeSH Term Description Entries
D010928 Placental Lactogen A polypeptide hormone of approximately 25 kDa that is produced by the SYNCYTIOTROPHOBLASTS of the PLACENTA, also known as chorionic somatomammotropin. It has both GROWTH HORMONE and PROLACTIN activities on growth, lactation, and luteal steroid production. In women, placental lactogen secretion begins soon after implantation and increases to 1 g or more a day in late pregnancy. Placental lactogen is also an insulin antagonist. Choriomammotropin,Chorionic Somatomammotropin, Human,Human Placental Lactogen,Lactogen Hormone, Placental,Mammotropic Hormone, Placental,Somatomammotropin, Chorionic,Choriomammotrophin,HCS (Human Chorionic Somatomammotropin),HPL (Human Placental Lactogen),PAPP-D,Placental Luteotropin,Pregnancy-Associated Plasma Protein D,Chorionic Somatomammotropin,Human Chorionic Somatomammotropin,Lactogen, Placental,Luteotropin, Placental,Placental Lactogen, Human,Placental Mammotropic Hormone,Pregnancy Associated Plasma Protein D
D011092 Polyethylene Glycols Polymers of ETHYLENE OXIDE and water, and their ethers. They vary in consistency from liquid to solid depending on the molecular weight indicated by a number following the name. They are used as SURFACTANTS, dispersing agents, solvents, ointment and suppository bases, vehicles, and tablet excipients. Some specific groups are NONOXYNOLS, OCTOXYNOLS, and POLOXAMERS. Macrogols,Polyoxyethylenes,Carbowax,Macrogol,Polyethylene Glycol,Polyethylene Oxide,Polyethyleneoxide,Polyglycol,Glycol, Polyethylene,Glycols, Polyethylene,Oxide, Polyethylene,Oxides, Polyethylene,Polyethylene Oxides,Polyethyleneoxides,Polyglycols,Polyoxyethylene
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

P Englebienne, and G Doyen, and R Dervaux, and J P Billemont
October 1978, Clinical chemistry,
P Englebienne, and G Doyen, and R Dervaux, and J P Billemont
March 1980, Clinical chemistry,
P Englebienne, and G Doyen, and R Dervaux, and J P Billemont
August 1965, The Journal of clinical endocrinology and metabolism,
P Englebienne, and G Doyen, and R Dervaux, and J P Billemont
August 1973, Prostaglandins,
P Englebienne, and G Doyen, and R Dervaux, and J P Billemont
June 1970, American journal of obstetrics and gynecology,
P Englebienne, and G Doyen, and R Dervaux, and J P Billemont
January 1983, Clinical chemistry,
P Englebienne, and G Doyen, and R Dervaux, and J P Billemont
July 1974, Ginecologia y obstetricia de Mexico,
P Englebienne, and G Doyen, and R Dervaux, and J P Billemont
December 1979, Kaku igaku. The Japanese journal of nuclear medicine,
P Englebienne, and G Doyen, and R Dervaux, and J P Billemont
March 1976, Clinical chemistry,
P Englebienne, and G Doyen, and R Dervaux, and J P Billemont
July 1968, Obstetrics and gynecology,
Copied contents to your clipboard!